accountAbbott Laboratories said Tuesday the Food and Drug Administration approved two longer-acting doses of its drug Lupron as a treatment for premature puberty.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Labs says FDA approves longer-acting Lupron
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account